At the meeting of the regional transfusion directors, it was noted that the most risky populations might had been identifiable by anti-HBc markers, however no further discussion took place. Read more about At the meeting of the regional transfusion directors, it was noted that the most risky populations might had been identifiable by anti-HBc markers, however no further discussion took place.
Dr Craske wrote to Dr Barbara that he did not favour the use of anti-HBc screening. Read more about Dr Craske wrote to Dr Barbara that he did not favour the use of anti-HBc screening.
The Chiron Corporation identified and cloned Hepatitis C virus. Read more about The Chiron Corporation identified and cloned Hepatitis C virus.
DHSS granted funding for multi-centre study. Read more about DHSS granted funding for multi-centre study.
Letter in The Lancet from SNBTS suggested that surrogate testing was "inescapable". Read more about Letter in The Lancet from SNBTS suggested that surrogate testing was "inescapable".
SNBTS minutes recorded decision to introduce surrogate testing next year. Read more about SNBTS minutes recorded decision to introduce surrogate testing next year.
Working Party on Transfusion-Associated Hepatitis reconvened for the first time since 1983 and proposed to discuss a protocol for a multi-centre study. Read more about Working Party on Transfusion-Associated Hepatitis reconvened for the first time since 1983 and proposed to discuss a protocol for a multi-centre study.
FDA recommended the introduction of both ALT and anti-HBc testing. Read more about FDA recommended the introduction of both ALT and anti-HBc testing.
Report produced on NANBH in the West of Scotland by Drs Dow and Follett. Read more about Report produced on NANBH in the West of Scotland by Drs Dow and Follett.
Working Party on Transfusion-Associated Hepatitis focused on AIDS – no further discussion of prospective study of NANBH markers. Read more about Working Party on Transfusion-Associated Hepatitis focused on AIDS – no further discussion of prospective study of NANBH markers.